Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith R McCrae

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Biorxiv : the Preprint Server for Biology|September 4, 2023
Protection of β2GPI Deficient Mice from Thrombosis Reflects a Defect in PAR3-facilitated Platelet ActivationParesh P Kulkarni, Ravi Kumar Alluri, Matthew Godwin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 26, 2018
Kininogen deficiency or depletion reduces enhanced pause independent of pulmonary inflammation in a house dust mite-induced murine asthma modelJack Yang, Cornelis van 't Veer, Joris J T H Roelofs, et al.
Platelets|April 22, 2020
Report of a 'consensus' on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle PiastrineLorenzo Cirasino, Anna M Robino, GianMarco Podda, et al.
Cancer Research|August 17, 2016
Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working GroupNigel S Key, Alok A Khorana, Nigel Mackman, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Genetic and Epigenetic Dysregulation of CR1 is Associated with Catastrophic Antiphospholipid Syndrome (CAPS)Nikhil Ranjan, Michael Cole, Gloria F Gerber, et al.
Cancer Research|September 18, 2002
Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domainJose C Juarez, Xiaojun Guan, Natalya V Shipulina, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Effects of anti-β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activityChristopher J Ng, Keith R McCrae, Katrina Ashworth, et al.
Annals of the Rheumatic Diseases|August 21, 2025
Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndromeNikhil Ranjan, Michael A Cole, Gloria F Gerber, et al.
Cancer Research|June 18, 2002
A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancerAfshin Dowlati, Kelly Robertson, Matthew Cooney, et al.
Blood|September 1, 2012
Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammationFriederike Langhauser, Eva Göb, Peter Kraft, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Biorxiv : the Preprint Server for Biology|September 4, 2023
Protection of β2GPI Deficient Mice from Thrombosis Reflects a Defect in PAR3-facilitated Platelet ActivationParesh P Kulkarni, Ravi Kumar Alluri, Matthew Godwin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 26, 2018
Kininogen deficiency or depletion reduces enhanced pause independent of pulmonary inflammation in a house dust mite-induced murine asthma modelJack Yang, Cornelis van 't Veer, Joris J T H Roelofs, et al.
Platelets|April 22, 2020
Report of a 'consensus' on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle PiastrineLorenzo Cirasino, Anna M Robino, GianMarco Podda, et al.
Cancer Research|August 17, 2016
Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working GroupNigel S Key, Alok A Khorana, Nigel Mackman, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Genetic and Epigenetic Dysregulation of CR1 is Associated with Catastrophic Antiphospholipid Syndrome (CAPS)Nikhil Ranjan, Michael Cole, Gloria F Gerber, et al.
Cancer Research|September 18, 2002
Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domainJose C Juarez, Xiaojun Guan, Natalya V Shipulina, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Effects of anti-β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activityChristopher J Ng, Keith R McCrae, Katrina Ashworth, et al.
Annals of the Rheumatic Diseases|August 21, 2025
Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndromeNikhil Ranjan, Michael A Cole, Gloria F Gerber, et al.
Cancer Research|June 18, 2002
A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancerAfshin Dowlati, Kelly Robertson, Matthew Cooney, et al.
Blood|September 1, 2012
Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammationFriederike Langhauser, Eva Göb, Peter Kraft, et al.
Pageof 16